Abstract

The COVID-19 vaccine is one way to prevent the spread of COVID-19. Indonesia has produced Indovac, a COVID-19 vaccine made by Biofarma which has the opportunity to be distributed to countries in the Indo-Pacific Region. This article aims to explain the opportunities and challenges of Indonesia's vaccine diplomacy during the COVID-19 pandemic to the Indo-Pacific region through Biofarma. By using a vaccine diplomacy approach and qualitative methods with System Dynamic analysis, this article concludes that (i) The opportunity for Indonesia's vaccine diplomacy to the Indo-Pacific is 44% and (ii) The simulation results for all parameters have the opportunity to increase Indonesia's progress in the Indo-Pacific except for the parameters of cooperation with special actors vaccine. The challenges for Indonesia's Covid-19 vaccine diplomacy to the Indo-Pacific come from the United States, India, Japan, Australia and Singapore.